NO16968_2A: NO16968, figure 2A

NO16968_2AR Documentation

NO16968, figure 2A

Description

Kaplan-Meier digitized data from NO16968, figure 2A (PMID 26324362). A reported sample size of 1,886 for a primary endpoint of DFS in colorectal cancer.

Usage

NO16968_2A

Format

A data frame of 1,886 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (fu_fa, xelox)

Source

Schmoll H-J, Tabernero J, Maroun J, et al. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. J Clin Oncol 2015; 33: 3733–40.

Examples

summary(NO16968_2A)

kmplot(NO16968_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.